4.5 Article

Catechol-O-methyltransferase Val158Met polymorphism: Modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease

Journal

PARKINSONISM & RELATED DISORDERS
Volume 20, Issue 10, Pages 1094-1096

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.parkreldis.2014.07.011

Keywords

COMT; Parkinson's disease; Levodopa; Wearing-off

Funding

  1. Natural Science Fund of China [81071024, 81171202, 30872729, 30870879]
  2. Shanghai Shuguang Program [11SG20]
  3. Fifth National Undergraduate Student Innovating Program [2011015]

Ask authors/readers for more resources

Catechol-O-methyltransferase (COMT) is one of the cardinal enzymes that metabolize dopamine and other catecholamine neurotransmitters in the central and peripheral nervous system. Recent studies have shown that the impact of COMT haplotypes on the development of wearing-off phenomenon is in dispute, while the relationship between COMT haplotypes and wearing-off phenomenon in ethnic Chinese population is lacking. The purpose of this study was to characterize the correlation between the Val158Met polymorphism in the COMT gene and the motor complication wearing-off in Chinese PD patients. We have sequenced the COMT gene in 259 PD patients and 257 healthy controls. Our results demonstrated that Met/Met homozygosity of the COMT Val158Met polymorphism was related to a decreased risk of developing wearing-off. This finding suggests that COMT Val158Met may affect susceptibility to wearing-off in PD. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available